While GLP-1 medications have revolutionized weight loss, recent studies suggest that their benefits may not be long-lasting for many users. Ongoing research shows that when patients stop taking GLP-1 drugs, they tend to regain the weight. According to research from the University of Oxford, experts estimate that many patients’ weight will return to pre-treatment levels within about 1.7 years after stopping medications. Cardiometabolic markers, such as blood pressure, cholesterol, and diabetes-related markers, tend to decline roughly 1.4 years after discontinuing the medications. ESG typically costs around $12,000, and VSG costs about $17,000.